How do insulin and glucagon help in treating beta blocker (beta-adrenergic blocking agent) overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin and Glucagon in Beta Blocker Overdose Management

High-dose insulin therapy and glucagon are both reasonable and effective treatments for beta blocker overdose with hemodynamic compromise, with insulin showing superior outcomes in severe cases.1

Mechanism of Action

Glucagon

  • Counteracts beta blocker effects by activating hepatic adenylate cyclase, promoting glucogenolysis through a pathway that bypasses the blocked beta-adrenergic receptors 2
  • Increases heart rate and improves atrioventricular conduction without requiring functional beta receptors 3
  • May increase cardiac output but has inconsistent effects on mean arterial pressure 4

High-Dose Insulin

  • Works through three main mechanisms: increased inotropy, increased intracellular glucose transport, and vascular dilation 5
  • Improves myocardial energy utilization during beta blocker toxicity 1
  • Particularly effective in severe beta blocker poisoning with cardiogenic shock 6

Treatment Protocol

Glucagon Administration

  • Initial dose: 3-10 mg IV administered slowly over 3-5 minutes 1, 2
  • Followed by continuous infusion of 3-5 mg/h (0.05-0.15 mg/kg/h) 1
  • Titrate infusion rate to achieve adequate hemodynamic response 1
  • Plan for adequate supply as treatment may require >100 mg in 24 hours 1

High-Dose Insulin Administration

  • Initial bolus: 1 U/kg regular insulin IV 1, 7
  • Accompanied by 0.5 g/kg dextrose bolus 1, 7
  • Followed by continuous infusion of 0.5-1 U/kg/h insulin and 0.5 g/kg/h dextrose 1, 7
  • Higher doses (up to 10 U/kg/h) may be required in severe cases 5, 6

Monitoring and Precautions

For Glucagon Therapy

  • Common side effect: vomiting - protect airway in patients with CNS depression 1
  • Monitor for potential interactions with dopamine, isoproterenol, and milrinone which may decrease glucagon effectiveness 1
  • Patients taking beta-blockers may experience transient increases in pulse and blood pressure when given glucagon 8

For Insulin Therapy

  • Very frequent glucose monitoring (every 15 minutes initially) 1, 7
  • Target serum glucose: 100-250 mg/dL (5.5-14 mmol/L) 1, 7
  • Monitor potassium levels - insulin causes intracellular potassium shift 1, 7
  • Target potassium levels: 2.5-2.8 mEq/L to avoid aggressive repletion 1, 7
  • Sustained infusions of concentrated dextrose solutions (>10%) require central venous access 1

Treatment Algorithm for Beta Blocker Overdose

  1. Initial Management:

    • Standard resuscitation measures (BLS/ACLS) 1, 2
    • IV fluids for volume resuscitation 5
  2. For Symptomatic Bradycardia or Hemodynamic Compromise:

    • Consider calcium (Class IIa, LOE C-LD) - 0.3 mEq/kg of calcium 1
    • Initiate glucagon (Class IIa, LOE C-LD) using protocol above 1, 2
  3. For Refractory Cases:

    • Implement high-dose insulin therapy (Class IIa, LOE C-LD) 1, 7
    • Evidence suggests high-dose insulin may be superior to conventional therapies including glucagon in severe cases 5, 6

Important Considerations

  • Early initiation of high-dose insulin in the emergency department can be beneficial rather than waiting for conventional therapies to fail 6
  • Animal studies and human case reports demonstrate that high-dose insulin is superior in terms of safety and survival compared to conventional therapies 5
  • For severe beta blocker overdose with cardiogenic shock, consider escalating to higher insulin doses (up to 10 U/kg/h) if standard doses are ineffective 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Beta Blocker Overdose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Glucagon therapy for beta-blocker overdose.

Drug intelligence & clinical pharmacy, 1984

Guideline

Uso de Insulina en la Intoxicación por Beta Bloqueantes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.